Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study

Creative Commons License

Cavolli R., Kaya K., Aslan A., Emiroglu O., Erturk S., Korkmaz O., ...Daha Fazla

CIRCULATION, cilt.118, sa.5, ss.476-481, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 118 Sayı: 5
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1161/circulationaha.107.719377
  • Dergi Adı: CIRCULATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.476-481
  • Anahtar Kelimeler: myocardial revascularization, atrial fibrillation, sodium nitroprusside, ARTERY-BYPASS SURGERY, CARDIAC-SURGERY, CARDIOPULMONARY BYPASS, RANDOMIZED-TRIAL, NITRIC-OXIDE, AMIODARONE, PREVENTION, PROPHYLAXIS, PLACEBO, COMBINATION
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Background - Atrial fibrillation ( AF) often occurs after coronary artery bypass grafting and can result in increased morbidity and mortality. In the present pilot study, our aim was to investigate whether sodium nitroprusside (SNP), as a nitric oxide donor, can reduce the frequency of post - coronary artery bypass grafting AF.